Yasuko Sugiyama
Overview
Explore the profile of Yasuko Sugiyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamura R, Kinoshita M, Yasumizu Y, Yata T, Kihara K, Motooka D, et al.
Front Immunol
. 2025 Feb;
16:1508977.
PMID: 39963140
Background: The advent of biologics has significantly transformed treatment strategies for neuromyelitis optica spectrum disorder (NMOSD). However, there are no biomarkers that predict relapses associated with steroid tapering; therefore, it...
2.
Kanakura M, Kihara K, Kinoshita M, Sugimoto T, Murata H, Beppu S, et al.
Clin Neurol Neurosurg
. 2024 Jun;
243:108378.
PMID: 38901377
Objectives: This study aimed to evaluate whether switching disease-modifying therapies (DMTs) from sphingosine-1 phosphate (S1P) receptor modulators to either natalizumab (NTZ) or dimethyl fumarate (DMF) could restore the effectiveness of...
3.
Shimizu M, Shiraishi N, Tada S, Sasaki T, Beck G, Nagano S, et al.
Sci Adv
. 2023 Nov;
9(47):eadg3193.
PMID: 37992159
Repulsive guidance molecule A (RGMa) was originally identified as a neuronal growth cone-collapsing factor. Previous reports have demonstrated the multifunctional roles of RGMa mediated by neogenin1. However, the pathogenic involvement...
4.
Sugiyama Y, Takata K, Kinoshita M, Motooka D, Shiraishi N, Kihara K, et al.
Biochem Biophys Res Commun
. 2023 Mar;
656:97-103.
PMID: 36958260
No abstract available.
5.
Kihara K, Kinoshita M, Sugimoto T, Okazaki S, Murata H, Beppu S, et al.
J Neurol Neurosurg Psychiatry
. 2023 Jan;
94(6):495-497.
PMID: 36596701
No abstract available.
6.
Murata H, Kinoshita M, Yasumizu Y, Motooka D, Beppu S, Shiraishi N, et al.
Neurol Neuroimmunol Neuroinflamm
. 2022 Feb;
9(3).
PMID: 35210295
Background And Objectives: Recently accumulating evidence suggests the pivotal role of type 1 interferon (IFN-1) signature in the pathogenesis of neuromyelitis optica spectrum disorder (NMOSD). However, the mechanism of the...
7.
Kidani Y, Nogami W, Yasumizu Y, Kawashima A, Tanaka A, Sonoda Y, et al.
Proc Natl Acad Sci U S A
. 2022 Feb;
119(7).
PMID: 35140181
Foxp3-expressing CD25CD4 regulatory T cells (Tregs) are abundant in tumor tissues. Here, hypothesizing that tumor Tregs would clonally expand after they are activated by tumor-associated antigens to suppress antitumor immune...
8.
Beppu S, Kinoshita M, Wilamowski J, Suenaga T, Yasumizu Y, Ogawa K, et al.
Sci Rep
. 2022 Jan;
12(1):106.
PMID: 34997058
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease characterized by the presence of pathogenic autoantibodies, anti-aquaporin 4 (AQP4) antibodies. Recently, HLA-DQA1*05:03 was shown to be significantly associated with...
9.
Okazaki T, Kodama D, Yamadera M, Sugiyama Y, Tsuji H, Nishida F, et al.
Rinsho Shinkeigaku
. 2021 Nov;
61(12):833-838.
PMID: 34789625
Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection caused by JC virus (JCV) activation. We report an 85-years old man who had been diagnosed to have rheumatoid arthritis (RA)...
10.
Ishikura T, Kinoshita M, Shimizu M, Yasumizu Y, Motooka D, Okuzaki D, et al.
J Neuroinflammation
. 2021 Aug;
18(1):181.
PMID: 34419102
Background: Intractable neuropathic pain is a common symptom of neuromyelitis optica spectrum disorder (NMOSD). However, the underlying mechanism of NMOSD pain remains to be elucidated. In this study, we focused...